# CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15/24 - 4/2/28

> **NIH NIH N01** · THE EMMES COMPANY, LLC · 2024 · $3,419,274

## Abstract

This contract supports work that is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to improve treatment for opioid misuse and addiction.

## Key facts

- **NIH application ID:** 11220970
- **Project number:** 75N95024D00037-0-759502400003-1
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** EVE JELSTROM
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $3,419,274
- **Award type:** —
- **Project period:** 2024-08-15 → 2028-04-02

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11220970

## Citation

> US National Institutes of Health, RePORTER application 11220970, CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15/24 - 4/2/28 (75N95024D00037-0-759502400003-1). Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/grant/nih/11220970. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*